N.B. Williamson

GnRH induces ovulation of a dominant follicle in primiparous dairy cows undergoing anovulatory follicle turnover

Abstract This trial examined the effect of an injection of gonadotropin-releasing hormone (GnRH) administered approximately 3 weeks postpartum on the induction of a luteinising hormone (LH) surge and ovulation of large (over 10 mm) follicles in the ovaries of lactating primiparous dairy cows likely to have an extended postpartum period of anovulation. At 2 weeks postpartum daily transrectal ultrasound of ovarian follicles commenced in 20 primiparous dairy cows which were randomly assigned to be injected i.m. with 250 μg GnRH or saline. Treatment was given the day after the largest growing follicle was over 10 mm in diameter. Blood samples were drawn hourly following treatment to measure plasma concentrations of LH. Milk samples were taken three times per week from 2 weeks postpartum to 3–4 weeks after treatment for analysis of progesterone concentration. Every primiparous cow treated with GnRH had an LH surge (over 10 ng ml −1 maximum concentration) which was maximal 2 h after treatment. Nine of the ten primiparous cows treated with GnRH and one saline-treated cow ovulated within 4 days of treatment. However, only three of the primiparous cows treated with GnRH continued to ovulate following the first, short (less than 10 day) luteal phase. These data indicate that sufficient releasable pituitary stores of LH were present at the time of treatment with GnRH and that large follicles are able to be ovulated. Hypothalamic release of GnRH, rather than pituitary or ovarian insufficiency, appears to be the factor limiting resumption of cyclic activity in these primiparous cows. Even though ovulation can be induced, it may not lead to the resumption of normal cyclicity.

The effect of estradiol benzoate administration on estrous response and synchronized pregnancy rate in dairy heifers after treatment with exogenous progesterone.

The objectives of this trial were to determine the effects of 0.5 mg estradiol benzoate administered intramuscularly 24 h after the removal of progesterone-containing intravaginal devices on the occurrence and timing of estrus, synchronized pregnancy rate and synchronized conception rate in dairy heifers. A clinical trial was conducted involving 750 dairy heifers in 13 herds. Within each herd heifers were randomly allocated to 1 of 2 estrus synchronization treatments. All heifers received a CIDR-B progesterone-containing intravaginal device containing a 10 mg estradiol benzoate capsule for 12 d. Twenty-four hours after CIDR-B removal one group received 0.5 mg, im estradiol benzoate while the other group received an intramuscular injection of a placebo. Estrus detection was performed at 48 and 72 h after intravaginal device removal, and heifers detected in estrus at those times were inseminated. Administration of estradiol benzoate 24 h after removal of CIDR-B devices significantly increased the number of heifers exhibiting estrus within the observation period (96.1 vs 90.5%; P < 0.01). It also altered the onset of estrus so that significantly more heifers were in estrus (86.6 vs 72.3%; P < 0.01) and conceived (47.1 vs 37.5%; P < 0.05) by 48 h after CIDR-B device removal. The synchronized conception rate was unaffected by treatment. The distribution of estrus was such that fixed-time insemination after estrus synchronization with this treatment program may be recommended.

Efficacy of a Neospora caninum killed tachyzoite vaccine in preventing abortion and vertical transmission in dairy cattle.

A clinical trial was undertaken to assess the efficacy of Bovilis(®) Neoguard, a killed Neospora caninum tachyzoite vaccine on 5 commercial dairy farms in New Zealand with a history of Neospora-associated abortion. Cattle were enrolled in the trial at 30-60 days of gestation and randomly allocated to treatment or control groups. Treatment consisted of 5 mL doses of Bovilis Neoguard administered subcutaneously at enrolment then 4 weeks later. Isotonic saline was administered to the control group. Of 2246 cattle enrolled in the trial, 10.7% of cows and 12.6% of heifers were seropositive to N. caninum. Sampling of a randomly selected proportion of enrolled animals 6 weeks after the second treatment showed that 188/232 (81.0%) vaccinated with Bovilis(®) Neoguard had seroconverted, while 11/130 (8.5%) cows and 10/36 (27.8%) heifers in the control group had seroconverted. Forty-eight vaccinated and 63 control animals aborted. On one farm 12.5% of control animals and 6.1% of vaccinated animals aborted (vaccine efficacy 0.61; p=0.03). On another farm with a high level of abortion 8.4% of control animals and 8.7% of vaccinates aborted. On the remaining 3 farms fewer abortions occurred than expected. A modified Poisson regression approach was used to calculate relative risks for abortion and vertical transmission. Overall vaccine efficacy was 0.25 (p=0.12). Heifer replacement calves from the animals enrolled in the trial were sampled for antibodies to N. caninum at 6-9 months of age. Fourteen of 17 calves from vaccinated, seropositive cows were seropositive as were 13/23 calves from seropositive cows in the control group. The interaction between dam serostatus and treatment group was significant (p=0.05) with vaccination increasing the risk of vertical transmission. It was concluded that vaccination after conception prevented 61% abortions in one of five herds and that vaccination may have increased the risk of early embryonic death.

A longitudinal study of Neospora caninum infection on a dairy farm in New Zealand.

A 600-cow New Zealand dairy herd experienced an abortion storm in 1997 and was monitored (blood sampling at about 3-month intervals) from May 1997 until January 1999. Abortion risk reached 9% in 1997 and was highest in heifers at 19%. The abortion risk decreased in 1998 to 3.2% (still somewhat higher than during the years prior to the outbreak). The serological reaction pattern for Neospora caninum showed an association with abortion risk only around the time of the 1997 outbreak when seropositive cows were 4.2 times more likely to abort than negative ones. Over the whole study period, only 27% of cows that were sampled on all nine visits always tested negative. Offspring from dams which had positive tests for Neospora caninum were 2.4 times more likely to abort than those from dams testing consistently negative. Controlling for age and breed, seropositive cows produced more milk than those that were consistently negative. Infection might have been present endemically within this herd prior to the epidemic, but in 1997 an additional factor appeared to have triggered the outbreak.

Ovulatory responses and plasma luteinizing hormone concentrations in dairy heifers after treatment with exogenous progesterone and estradiol benzoate.

The objectives of this experiment were to determine the effects of 0.5 mg estradiol benzoate, administered intramuscularly 24 h after removal of CIDR-B progesterone containing intravaginal devices, on the time to estrus, ovulation and peak LH concentration in dairy heifers. Ovulatory responses and plasma LH concentrations were examined using 14 Friesian dairy heifers in 2 separate treatment periods. All heifers received a CIDR-B progesterone-containing intravaginal device with an attached 10-mg estradiol benzoate capsule for 12 d. Within each period, 24 h after CIDR-B removal, 7 heifers received an intramuscular injection of 0.5 mg estradiol benzoate while the remaining 7 heifers received an intramuscular injection of a placebo. Blood samples for LH assay were collected at 0, 6 and 12 h, and then every 4 h for 60 h after estradiol injection. Detection of estrus was conducted at 4-h intervals, and ultrasonographical examination to detect ovulation was conducted every 8 h for 88 h after removal of the CIDR-B device. Treatment with estradiol benzoate tended to reduce the time from device removal to the LH peak in Period 1 (median time to LH peak 40.1 vs 63.9 h; P = 6.07). In Period 2, treatment with estradiol had no significant effect on the time to the LH peak, standing estrus or ovulation. We hypothesize that the period effect was due to the stage of cycle at the time of treatment. For heifers treated in Period 1, the stage of cycle was random. However, because of the prior synchronization of estrus, which was implicit in the experimental design, heifers in Period 2 tended to be in late diestrus. The administration of estradiol benzoate after treatment with exogenous progesterone appears to overcome the variability in timing of LH peaks typically occurring in a herd of synchronized heifers due to different stages of follicular development.

The effect of intra-ruminal selenium pellets on growth rate, lactation and reproductive efficiency in dairy cattle.

In each of two dairy herds (A and B), rising yearling heifers (Trial 1) and adult cows (Trial 2) were assigned to three treatment groups. Untreated animals were compared to animals treated with either two or four intra-ruminal pellets containing 3 g of elemental selenium. The administration of pellets at the recommended dose (two pellets per animal) was effective in elevating whole blood glutathione peroxidase activity and selenium concentration to over 10 times those of control animals. In Trial 1, a 15% response in liveweight gain (p<0.001) occurred in yearling heifers in the herd with the lowest pre-treatment selenium status. In Trial 2, cows receiving two pellets produced a greater milk volume (p=0.06) and more milk solids (p=0.02) than untreated controls; an increase in volume of 5.4% and 8%, and in milk solids of 6.5% and 6.4%, were noted in herds A and B respectively. There was a trend towards decreasing somatic cell counts in milk from the treated cows when compared to controls, the four-pellet group in Herd A and the two-pellet group in Herd B being significantly different from their respective control group. No between-group differences were noted in calving-first service or calving-conception intervals, nor in the proportion of animals pregnant to first or all services. The administration of selenium at twice the recommended dose rate yielded no additional response above that noted after the administration of the recommended dose. The results of this study support the use of currently recommended Ministry of Agriculture and Fisheries selenium reference ranges in cattle for the prediction of a response to supplementation.

The incidence and aetiology of clinical bovine mastitis on 14 farms in Northland, New Zealand

Abstract AIM: To estimate the incidence of clinical mastitis and the frequency of isolation of mastitis-causing organisms from clinical cases in one lactation season (July 2005 to May 2006) on 14 dairy farms from the Northland region of New Zealand. METHODS: Cases of clinical mastitis were determined by trained farm personnel who recorded the identity of affected cows. Pooled milk samples from affected quarter(s) were aseptically collected by the farm personnel, for microbiology. Mean numbers of affected cows and quarters were compared at the population and farm level per 305 cow-days-at-risk (DAR). RESULTS: One or more cases of clinical mastitis occurred in 559/3,765 (14.8%) lactating cows. The average incidence of clinical mastitis was 0.19 cases per 305 DAR. The incidence in rear quarters (56.2%) was 1.3 times (p=0.027) that of front quarters (43.8%). The incidence of clinical mastitis and numbers of affected quarters were signifi cantly infl uenced by the stage of lactation (higher in early lactation), age (higher in older cows) and farm. At the cow level, the most common isolates were Staphylococcus aureus (23.7%) and Streptococcus uberis (23.3%). No causative organisms were identifi ed in 19.9% of the samples. Each cow had an average of 1.8 quarters affected during a case of clinical mastitis. CONCLUSIONS: This study demonstrated a higher incidence of staphylococcal clinical mastitis on dairy farms from Northland than has been reported in other regions of New Zealand.

Isolation and molecular characterisation of Neospora caninum in cattle in New Zealand

Abstract AIM: To isolate Neospora caninum from the brains of naturally infected cattle and use molecular techniques to characterise the isolates. METHODS: Neospora caninum tachyzoites were isolated in Vero cell culture from the brains of a cow and two calves. The isolates were characterised using polymerase chain reaction (PCR) methods, DNA sequencing, an immunofluorescent anti-body test (IFAT), transmission electron microscopy (TEM), and immunohistochemistry (IHC). The brains of the three cattle were subjected to histopathological examination. A pathogenicity study was conducted in 120 BALB/c mice. RESULTS: Neospora caninum tachyzoites were isolated from all three cases and first observed in vitro between 14 and 17 days post-inoculation. Parasites were sub-cultured and maintained in Vero cell culture for more than 6 months. PCR products were generated for all three isolates, using two different primers. Sequencing of the PCR products and a subsequent BLAST search identified the isolates as N. caninum. In addition, the isolates tested positive using IFAT and IHC, and ultrastructure revealed by TEM was characteristic of N. caninum. Histopathological examination revealed lesions characteristic of N. caninum in 1/3 brains. In the pathogenicity study using BALB/c mice, the mortality rate was 3–7%. CONCLUSION: This was the first successful isolation of N. caninum in New Zealand confirmed using molecular characterisation tests.

Effects of selenium and iodine supplementation on the growth rate, mohair production, and thyroid status of Angora goat kids

Abstract The aim of this study was to examine the effect of supplementation with either selenium (Se) or iodine (I), or both, on growth rate, mohair production, and plasma concentrations of thyroid hormones in Angora goat kids. Kids were treated with 0 or 1 intraruminal Se pellet, or treated intramuscularly with iodised oil at doses of 0, 200, or 400 mg I in a 2 × 3 factorial design. The concentrations of Se and I in the lucerne diet were 0.02 and 0.09 mg/kg dry matter (DM), respectively. Supplementary Se enhanced (P < 0.05) liveweight gain by 26% during the final month of the study, however mohair growth was not affected by either treatment. The plasma concentration of total thyroxine was increased (P < 0.001) by I treatment but decreased (P < 0.001) by Se treatment. The plasma concentration of total triiodothyronine was reduced (P < 0.001) by I treatment but unaffected by Se treatment. Thus, Se supplementation improved the liveweight gain of Angora goats but I supplementation had no effect on growth. Bo...

Prevalence of antibodies to Neospora caninum in dogs of rural or urban origin in central New Zealand

Abstract AIM: To investigate the seroprevalence of Neospora caninum infection in populations of dogs from dairy farms, sheep/beef farms and urban areas in the central part of New Zealand. It was postulated seroprevalence would be higher for farm dogs than urban dogs if the life-cycle of this parasite involves transmission between dogs and cattle. METHODS: Serum samples were obtained from dogs that lived on dairy farms (n=161), sheep/beef farms (n=154) and in urban situations (n=150). The relative risk of detecting antibodies to N. caninum using an immunofluorescent antibody test (IFAT) was compared between farm and urban dogs. RESULTS: The relative risk of having a titre of ≥1:200 to N. caninum was 2.43 (95% CI=1.88-3.14) for dairy-farm dogs and 3.16 (95% CI=2.48–4.02) for sheep/beef-farm dogs, compared with urban dogs. At this titre, which is currently used in New Zealand to indicate seropositivity, seroprevalence of N. caninum infection was 30.7% in urban dogs, 74.5% in dairy-farm dogs and 96.8% in sheep/beef-farm dogs. CONCLUSION: This observation is consistent with a cycling of this disease between cattle and dogs on farms in New Zealand and with higher exposure of dogs to N. caninum on farms than occurs in urban environments. The prevalence of antibodies in all three groups of dogs tested in this study (dairy-farm dogs, sheep/beef-farm dogs and urban dogs) is higher than has generally been reported elsewhere. New Zealand farm dogs have a higher serological prevalence of N. caninum infection than urban dogs. CLINICAL RELEVANCE: Management and disease control practices that break the life-cycle of transmission between cattle and dogs should assist in controlling cattle abortion due to N. caninum.